• 11.09.2019 – 17:00

  Jennewein Biotechnologie GmbH

  Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

  Rheinbreitbach (ots) - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC. In the ...

  more

• 05.02.2019 – 10:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market

  Hohhot, China & Rheinbreitbach, Germany (ots) - - China represents the largest market for baby food globally - Human milk oligosaccharides are key for the development of a healthy infant microbiome Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO), ...

  more

• 05.07.2018 – 12:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany

  Rheinbreitbach (ots) - Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms. "The relocation of part of our ...

  more